Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

The prognosis of advanced esophageal cancer patients is poor. Trimodality therapy of surgical resection plus neoadjuvant chemoradiotherapy (CRT) has been developed to improve survival through locoregional control, leading to prevention of micrometastasis. We investigated whether or not neoadjuvant C...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: FUJIWARA, YOSHINORI, YOSHIKAWA, REIGETSU, KAMIKONYA, NORIHIKO, NAKAYAMA, TSUYOSHI, KITANI, KOTARO, TSUJIE, MASANORI, YUKAWA, MASAO, INOUE, MASATOSHI, YAMAMURA, TAKEHIRA
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2012
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583592/
https://ncbi.nlm.nih.gov/pubmed/22664791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2012.1847
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items